Delivery Order SPE2DB22D1106-SPE2DB25FDSP2

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract has a firm fixed price of $6,905.40 and an ultimate completion date of April 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,528.24 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to treat opioid overdose. The contract has an ultimate completion date of November 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.12 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,564.64, is a delivery order for 4,560,883,236 units of NARCAN 4 MG NASAL SPRAY 2S. This order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,432.54 firm fixed-price delivery order is for the supply of 4,559,216,451 units of NARCAN 4 mg nasal spray. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract has a firm fixed price of $4,309.94 and a completion date of August 23, 2024. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,605.82, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The order has a firm fixed price and an ultimate completion date of April 22, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award, valued at $8,579.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The contract is a Firm Fixed Price Delivery Order with a completion date of May 2, 2024. Amerisourcebergen, through its Corporate Office Division, is a prominent supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $34,599.69 firm-fixed price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract has an ultimate completion date of September 9, 2024 and was awarded on September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $2,354.53 firm-fixed-price contract has an ultimate completion date of January 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDSP2
    Delivery Order

This is a $4,641.63 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NARCAN 4 MG NASAL SPRAY 2S. The award does not have a set-aside designation, indicating open competition.

The contract runs through January 3, 2025 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen plays a critical role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical supplies, to various federal government agencies and healthcare programs.

Generated 4/6/25, 12:48 AM